Strategic Oncology Entry Savoy's focus on oncology and virology with a first product targeting a cancer cell surface protein creates a clear entry point for early-stage oncology partnerships, CROs, and specialty manufacturers to support development, manufacturing scale-up, and potential licensing.

Lean Outsourcing Model With a small team, Savoy could greatly benefit from outsourced GMP manufacturing, formulation development, and clinical supply services to accelerate trials and reduce internal resource burdens.

Data-Driven Partnership Their tech stack including Google Cloud and analytics tools signals openness to cloud-based data management, trial data systems, biomarker analysis, and regulatory reporting partnerships.

Licensing Partnerships Position Savoy for co-development or licensing deals with larger pharma by emphasizing the unique target, potential for minimized side effects, and speed to market in oncology.

Market Engagement Engage with research institutions, key opinion leaders, and patient groups to support trial recruitment, advocacy, and visibility in oncology and virology spaces.